Remove 2015 Remove Communication Remove Insurance
article thumbnail

GSK’s world-first gonorrhoea vaccine launched in England

Pharmaceutical Technology

The vaccine was approved in Europe in 2013, with the UK becoming the first country to offer the vaccine as part of its routine childhood immunisation schedule in 2015. GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate? Don’t let policy changes catch you off guard.

article thumbnail

Alfasigma sets stage for Jyseleca in axSpA after Phase III win

Pharmaceutical Technology

However, this deal was terminated by Abbot, which spun out into AbbVie in 2015, as the company decided to pursue its own JAK1 inhibitor Rinvoq (upadacitinib), which was approved in the indication by the US Food and Drug Administration (FDA) in 2019. Give your business an edge with our leading industry insights.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA publishes more than 200 archived CRLs for transparency

Pharmaceutical Technology

Due to confidentiality around pending applications, sponsors could misrepresent significant details from FDA feedback when communicating with investors and other interested parties. GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate? Don’t let policy changes catch you off guard.

FDA
article thumbnail

FDA creates new priority review voucher scheme to boost US interests

Pharmaceutical Technology

In 2015, AbbVie spent $350m for a voucher to United Therapeutics, a market high, but voucher prices have gone down as more have become available for sale. A key incentive for those securing vouchers has been the ability to sell them to other pharma companies , with deals averaging around $100m in recent times, as per a GlobalData analysis.

FDA
article thumbnail

From data to impact: How real-world evidence will transform healthcare

pharmaphorum

Skip to main content Monday 7 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

article thumbnail

Bavarian Nordic nets $160m from priority review voucher sale

Pharmaceutical Technology

The record for the most expensive PRV occurred in 2015 when AbbVie bought a voucher from United Therapeutics for $350m. By GlobalData Learn more about Strategic Intelligence Sale figures increasing after dip PRVs were introduced in 2012 to incentivise development into non-lucrative disease areas.

FDA
article thumbnail

What we’re expecting in 2021, and beyond…

pharmaphorum

Kristin Milburn is managing director at Healthware Labs, which was launched in New York in 2015 with a mission to accelerate digital health and therapeutic innovation. Ariel Salmang is managing director at Intouch International, a unique joint venture between Healthware Group and the Intouch Group.